Long
Weekly breakout
COR-003 (levoketoconazole) - LOGICS
Endogenous Cushing’s syndrome
Phase 3 top line data expected 2Q or 3Q 2020
Endogenous Cushing’s syndrome
Phase 3 top line data expected 2Q or 3Q 2020
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.